Literature DB >> 34044153

SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assay.

Wollschlaeger P1, Todt D2, Gerlitz N1, Pfaender S3, Bollinger T4, Sing A5, Dangel A5, Ackermann N5, Korn K6, Ensser A6, Steinmann E3, Buhl M1, Steinmann J7.   

Abstract

OBJECTIVES: Detection and surveillance of SARS-CoV-2 is of eminent importance, particularly due to the rapid emergence of variants of concern (VOCs). In this study we evaluated if commercially available quantitative real-time PCR (qRT-PCR) assay can identify SARS-CoV-2 B.1.1.7 lineage samples by a specific N gene dropout or Ct value shift compared to the S or RdRp gene.
METHODS: VOC B.1.1.7 and non-B.1.1.7 SARS-CoV-2-positive patient samples were identified via whole-genome sequencing and variant-specific PCR. Confirmed B.1.1.7 (n=48) and non-B.1.1.7 samples (n=58) were analysed using the Allplex™ SARS-CoV-2/FluA/FluB/RSV™ PCR assay for presence of SARS-CoV-2 S, RdRp and N gene. N gene coding sequence of SARS-CoV-2 with and without D3L mutation (specific for B.1.1.7) was cloned into pCR®-TOPO vectors to validate polymorphism dependent N gene dropout with Allplex™ SARS-CoV-2/FluA/FluB/RSV™ PCR assay.
RESULTS: All studied B.1.1.7-positive patient samples showed significantly higher Ct values in qRT-PCR (Δ 6-10, N gene dropout on Ct values >29) of N gene compared to the corresponding values of S (p ≤ 0.0001) and RdRp (p ≤ 0.0001) genes. The assay reliably discriminated B.1.1.7 and non-B.1.1.7 positive samples (area under the curve AUC = 1) in a receiver operating characteristic (ROC) curve analysis. Identical Ct shifts (Δ 7-10) were detected in reverse genetic experiments, using isolated plasmids containing N gene coding sequences corresponding to D3 or 3L variants.
CONCLUSIONS: A N gene dropout or Ct value shift is shown for B.1.1.7-positive samples in the Allplex™ SARS-CoV-2/FluA/FluB/RSV PCR assay. This approach can be used as a rapid tool for B.1.1.7 detection in single assay high throughput diagnostics.
Copyright © 2021 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  B.1.1.7; Diagnostic quantitative RT-PCR; SARS-CoV-2; mutation

Year:  2021        PMID: 34044153     DOI: 10.1016/j.cmi.2021.05.025

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  21 in total

1.  Nationwide Harmonization Effort for Semi-Quantitative Reporting of SARS-CoV-2 PCR Test Results in Belgium.

Authors:  Lize Cuypers; Jannes Bode; Kurt Beuselinck; Lies Laenen; Klaas Dewaele; Reile Janssen; Arnaud Capron; Yves Lafort; Henry Paridaens; Bertrand Bearzatto; Mathieu Cauchie; Aline Huwart; Jonathan Degosserie; Olivier Fagnart; Yarah Overmeire; Arlette Rouffiange; Ilse Vandecandelaere; Marine Deffontaine; Thomas Pilate; Nicolas Yin; Isabel Micalessi; Sandrine Roisin; Veronique Moons; Marijke Reynders; Sophia Steyaert; Coralie Henin; Elena Lazarova; Dagmar Obbels; François E Dufrasne; Hendri Pirenne; Raf Schepers; Anaëlle Collin; Bruno Verhasselt; Laurent Gillet; Stijn Jonckheere; Philippe Van Lint; Bea Van den Poel; Yolien Van der Beken; Violeta Stojkovic; Maria-Grazia Garrino; Hannah Segers; Kevin Vos; Maaike Godefroid; Valerie Pede; Friedel Nollet; Vincent Claes; Inge Verschraegen; Pierre Bogaerts; Marjan Van Gysel; Judith Leurs; Veroniek Saegeman; Oriane Soetens; Merijn Vanhee; Gilberte Schiettekatte; Evelyne Huyghe; Steven Martens; Ann Lemmens; Heleen Nailis; Kim Laffineur; Deborah Steensels; Elke Vanlaere; Jérémie Gras; Gatien Roussel; Koenraad Gijbels; Michael Boudewijns; Catherine Sion; Wim Achtergael; Wim Maurissen; Luc Iliano; Marianne Chantrenne; Geert Vanheule; Reinoud Flies; Nicolas Hougardy; Mario Berth; Vanessa Verbeke; Robin Morent; Anne Vankeerberghen; Sébastien Bontems; Kaat Kehoe; Anneleen Schallier; Giang Ho; Kristof Bafort; Marijke Raymaekers; Yolande Pypen; Amelie Heinrichs; Wim Schuermans; Dominique Cuigniez; Salah Eddine Lali; Stefanie Drieghe; Dieter Ory; Marie Le Mercier; Kristel Van Laethem; Inge Thoelen; Sarah Vandamme; Iqbal Mansoor; Carl Vael; Maxime De Sloovere; Katrien Declerck; Elisabeth Dequeker; Stefanie Desmet; Piet Maes; Katrien Lagrou; Emmanuel André
Journal:  Viruses       Date:  2022-06-14       Impact factor: 5.818

2.  Multicenter study evaluating one multiplex RT-PCR assay to detect SARS-CoV-2, influenza A/B, and respiratory syncytia virus using the LabTurbo AIO open platform: epidemiological features, automated sample-to-result, and high-throughput testing.

Authors:  Hsing-Yi Chung; Ming-Jr Jian; Chih-Kai Chang; Jung-Chung Lin; Kuo-Ming Yeh; Ya-Sung Yang; Chien-Wen Chen; Shan-Shan Hsieh; Sheng-Hui Tang; Cherng-Lih Perng; Feng-Yee Chang; Kuo-Sheng Hung; En-Sung Chen; Mei-Hsiu Yang; Hung-Sheng Shang
Journal:  Aging (Albany NY)       Date:  2021-12-12       Impact factor: 5.682

3.  First Case of a COVID-19 Patient Infected by Delta AY.4 with a Rare Deletion Leading to a N Gene Target Failure by a Specific Real Time PCR Assay: Novel Omicron VOC Might Be Doing Similar Scenario?

Authors:  Mohammad Alkhatib; Maria Concetta Bellocchi; Greta Marchegiani; Sandro Grelli; Valeria Micheli; Daniele Stella; Bartolomeo Zerillo; Luca Carioti; Valentina Svicher; Paola Rogliani; Francesca Ceccherini-Silberstein
Journal:  Microorganisms       Date:  2022-01-25

4.  Detection of SARS-CoV-2 Omicron variant (B.1.1.529) infection of white-tailed deer.

Authors:  Kurt J Vandegrift; Michele Yon; Meera Surendran-Nair; Abhinay Gontu; Saranya Amirthalingam; Ruth H Nissly; Nicole Levine; Tod Stuber; Anthony J DeNicola; Jason R Boulanger; Nathan Kotschwar; Sarah Grimké Aucoin; Richard Simon; Katrina Toal; Randall J Olsen; James J Davis; Dashzeveg Bold; Natasha N Gaudreault; Juergen A Richt; James M Musser; Peter J Hudson; Vivek Kapur; Suresh V Kuchipudi
Journal:  bioRxiv       Date:  2022-02-07

5.  SARS-CoV2 RT-PCR assays: In vitro comparison of 4 WHO approved protocols on clinical specimens and its implications for real laboratory practice through variant emergence.

Authors:  Mariem Gdoura; Imen Abouda; Mehdi Mrad; Imen Ben Dhifallah; Zeineb Belaiba; Wasfi Fares; Anissa Chouikha; Maroua Khedhiri; Kaouther Layouni; Henda Touzi; Amel Sadraoui; Walid Hammemi; Zina Meddeb; Nahed Hogga; Sihem Ben Fadhel; Sondes Haddad-Boubaker; Henda Triki
Journal:  Virol J       Date:  2022-03-28       Impact factor: 4.099

6.  Comparison of three molecular diagnostic assays for SARS-CoV-2 detection: Evaluation of analytical sensitivity and clinical performance.

Authors:  Ha Nui Kim; Soo-Young Yoon; Chae Seung Lim; Jung Yoon
Journal:  J Clin Lab Anal       Date:  2022-01-12       Impact factor: 2.352

7.  Clinical Comparative Evaluation of the LabTurboTM AIO® Reverse Transcription-Polymerase Chain Reaction and World Health Organization-Recommended Assays for the Detection of Emerging SARS-CoV-2 Variants of Concern.

Authors:  Chih-Kai Chang; Ming-Jr Jian; Hsing-Yi Chung; Jung-Chung Lin; Shan-Shan Hsieh; Sheng-Hui Tang; Cherng-Lih Perng; Chien-Wen Chen; Kuo-Sheng Hung; Feng-Yee Chang; Hung-Sheng Shang
Journal:  Infect Drug Resist       Date:  2022-02-22       Impact factor: 4.003

Review 8.  The Emerging Concern and Interest SARS-CoV-2 Variants.

Authors:  Edyta Janik; Marcin Niemcewicz; Marcin Podogrocki; Ireneusz Majsterek; Michal Bijak
Journal:  Pathogens       Date:  2021-05-21

9.  Low Represented Mutation Clustering in SARS-CoV-2 B.1.1.7 Sublineage Group with Synonymous Mutations in the E Gene.

Authors:  Paolo Giuseppe Bonacci; Dalida Angela Bivona; Dafne Bongiorno; Stefano Stracquadanio; Mariacristina Massimino; Carmelo Bonomo; Alessia Stracuzzi; Paolo Pennisi; Nicolò Musso; Stefania Stefani
Journal:  Diagnostics (Basel)       Date:  2021-12-07

10.  A deletion in the N gene of SARS-CoV-2 may reduce test sensitivity for detection of SARS-CoV-2.

Authors:  Huanyu Wang; Sophonie Jean; Sarah A Wilson; Jocelyn M Lucyshyn; Sean McGrath; Richard K Wilson; Vincent Magrini; Amy L Leber
Journal:  Diagn Microbiol Infect Dis       Date:  2021-12-29       Impact factor: 2.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.